| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.73B | +33.1% |
| Cost of Revenue | $314.3M | +21.4% |
| Gross Profit | $1.42B | +36.0% |
| R&D Expense | $442.0M | +46.4% |
| SG&A Expense | $197.7M | +36.4% |
| Operating Income | -$109.1M | -99.1% |
| Interest Expense | $3.8M | -87.6% |
| Pre-tax Income | -$104.7M | -41.8% |
| Income Tax | $8.1M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $331.0M | -12.2% |
| Accounts Receivable | $226.8M | +44.2% |
| Current Assets | $1.75B | +20.7% |
| Total Assets | $2.54B | +17.0% |
| Current Liabilities | $761.7M | +23.3% |
| Total Liabilities | $1.55B | +19.3% |
| Stockholders' Equity | $992.2M | +13.6% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $273.2M | +14.4% |
| Capital Expenditures | $37.4M | +30.3% |
| Investing Cash Flow | -$319.7M | -78.1% |
| Financing Cash Flow | $7.4M | +114.4% |
| Free Cash Flow | $235.7M | +12.3% |
| +100.5% |
| Net Income | -$112.7M | -44.9% |
| EPS (Basic) | -$2.35 | -41.6% |
| EPS (Diluted) | -$2.35 | -41.6% |